Financial Partners Group LLC Raises Holdings in Humana Inc. (NYSE:HUM)

Financial Partners Group LLC raised its position in Humana Inc. (NYSE:HUMFree Report) by 1.3% during the third quarter, HoldingsChannel reports. The firm owned 18,591 shares of the insurance provider’s stock after purchasing an additional 241 shares during the period. Humana comprises 2.2% of Financial Partners Group LLC’s holdings, making the stock its 15th biggest position. Financial Partners Group LLC’s holdings in Humana were worth $5,889,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brookstone Capital Management purchased a new position in Humana in the 1st quarter worth approximately $448,000. 180 Wealth Advisors LLC boosted its stake in Humana by 8.1% during the first quarter. 180 Wealth Advisors LLC now owns 1,023 shares of the insurance provider’s stock worth $355,000 after buying an additional 77 shares during the last quarter. Independence Bank of Kentucky grew its holdings in Humana by 93.7% in the 1st quarter. Independence Bank of Kentucky now owns 1,259 shares of the insurance provider’s stock valued at $437,000 after buying an additional 609 shares in the last quarter. Opinicus Capital Inc. grew its holdings in Humana by 59.1% in the 1st quarter. Opinicus Capital Inc. now owns 1,974 shares of the insurance provider’s stock valued at $684,000 after buying an additional 733 shares in the last quarter. Finally, MCF Advisors LLC increased its stake in shares of Humana by 36.4% in the 1st quarter. MCF Advisors LLC now owns 3,863 shares of the insurance provider’s stock worth $1,342,000 after acquiring an additional 1,031 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Leerink Partnrs cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Stephens restated an “equal weight” rating and set a $250.00 price target on shares of Humana in a report on Wednesday, October 9th. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. Finally, Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price for the company in a research note on Tuesday, October 8th. One analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $315.33.

View Our Latest Stock Analysis on Humana

Humana Stock Performance

Shares of HUM stock opened at $258.41 on Friday. The firm has a 50 day moving average of $310.28 and a two-hundred day moving average of $337.43. The stock has a market capitalization of $31.14 billion, a PE ratio of 16.09, a P/E/G ratio of 1.91 and a beta of 0.50. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same period last year, the firm earned $8.94 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, research analysts predict that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.37%. Humana’s dividend payout ratio is presently 22.04%.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.